Rosett Max has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 31848 shares of Immunome Inc. ($IMNM) on April 02, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Common Stock | 31848 | $1.05 | 79,324.0000 | 91,710,277 | 67.08% | 0.03% |
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Stock option (right to buy) | 39713 | $0.00 | 0.0000 | 91,710,277 | 100.00% | 0.04% |
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Stock option (right to buy) | 31848 | $0.00 | 60,000.0000 | 91,710,277 | 34.67% | 0.03% |
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | S | Common Stock | 1344 | $22.48 | 54,037.0000 | 91,710,277 | 2.43% | 0.00% |
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | S | Common Stock | 63656 | $21.91 | 55,381.0000 | 91,710,277 | 53.48% | 0.07% |
| April 2, 2026 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Common Stock | 39713 | $1.35 | 119,037.0000 | 91,710,277 | 50.06% | 0.04% |
| July 29, 2025 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | A | Employee Stock Option (right to buy) | 207000 | $0.00 | 207,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Stock option (right to buy) | 42000 | $0.00 | 91,848.0000 | 0 | 31.38% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | S | Common Stock | 14380 | $16.01 | 47,476.0000 | 0 | 23.25% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Common Stock | 42000 | $1.05 | 61,856.0000 | 0 | 211.52% | 0.00% |
| Aug. 9, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, OPERATIONS & INTERIM CFO | A | Stock option (right to buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |